Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations in PKD1 and PKD2 genes that encode polycystin-1 and -2 (PC1 and PC2), respectively, is the most common lethal monogenic genetic diseases (ADPKD) of man, affecting ~1 in 1,000 individuals. ADPKD leads to cystic replacement of renal tissue and progressive renal failure, requiring renal replacement therapy in half of the cases by age 50. It is a systemic disease involving the kidney, liver, pancreas, arteries and heart. Using cells derived from mice with a targeted Pkd1mutation, we have recently shown that cells lacking functional PC1 formed cilia but did not increase calcium influx in response to physiological fluid flow. Blocking antibodies directed against PC2 similarly abolished the flow response in wild-type cells as did inhibitors of the ryanodine receptor, whereas inhibitors of G-proteins, phospholipase C and IPS receptors had no effect. These data led us to propose a model in which PC1 and PG2 form a mechanosensitive receptor channel complex and mediate fluid flow sensation in primary cilia of renal epithelia. Two lines of investigations are proposed in this competitive renewal. First, we aim to validate our hypothesis in both immortalized and freshly isolated primary cells from normal human individuals and cysts of ADPKD patients. We will also determine whether haplo-insufficiency is sufficient to affect flow sensing ability of renal epithelia. Second, we propose to test the hypothesis that PC1 mediated G protein signaling pathway is modulated by flow stimulation. In the last funding period, we showed that PC1 acts as a G-protein coupled receptor and its activation of G protein is inhibited by PC2.Here we hypothesize that this inhibition is regulated by physiological stimulations such as urine flow and will further dissect the downstreampathways of PC1 mediated G protein signaling. We believe our studies are of high significance and will provide novel insights into polycystin function and the molecular mechanisms underlying the pathogenesis of polycystic kidney disease. These studies are also likely to facilitate the development of therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK040703-18S1
Application #
7646029
Study Section
Special Emphasis Panel (ZRG1-RUS-G (02))
Program Officer
Rasooly, Rebekah S
Project Start
1989-01-01
Project End
2011-01-31
Budget Start
2008-07-01
Budget End
2009-01-31
Support Year
18
Fiscal Year
2008
Total Cost
$12,600
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Yao, Gang; Luo, Chong; Harvey, Michael et al. (2016) Disruption of polycystin-L causes hippocampal and thalamocortical hyperexcitability. Hum Mol Genet 25:448-58
Su, Xuefeng; Wu, Maoqing; Yao, Gang et al. (2015) Regulation of polycystin-1 ciliary trafficking by motifs at its C-terminus and polycystin-2 but not by cleavage at the GPS site. J Cell Sci 128:4063-73
Yao, Gang; Su, Xuefeng; Nguyen, Vy et al. (2014) Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex. Hum Mol Genet 23:2769-79
Yao, Gang; Luyten, Annouck; Takakura, Ayumi et al. (2013) The cytoplasmic protein Pacsin 2 in kidney development and injury repair. Kidney Int 83:426-37
Qin, Shan; Taglienti, Mary; Cai, Lei et al. (2012) c-Met and NF-ýýB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J Am Soc Nephrol 23:1309-18
Takakura, Ayumi; Nelson, Erik A; Haque, Nadeem et al. (2011) Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet 20:4143-54
Luyten, Annouck; Su, Xuefeng; Gondela, Sarah et al. (2010) Aberrant regulation of planar cell polarity in polycystic kidney disease. J Am Soc Nephrol 21:1521-32
Qin, Shan; Taglienti, Mary; Nauli, Surya M et al. (2010) Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. J Clin Invest 120:3617-28
Subramanian, Balajikarthick; Rudym, Darya; Cannizzaro, Chris et al. (2010) Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng Part A 16:2821-31
Takakura, Ayumi; Contrino, Leah; Zhou, Xiangzhi et al. (2009) Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet 18:2523-31

Showing the most recent 10 out of 39 publications